OncoSuite is a collection of modules all supporting aspects of clinical needs within oncology. These are all designed by clinicians for clinicians and are based on more than ten years of experience with applications for the oncology market. It currently consists of the products oncoSuite, oncoPlan, oncoMed and oncoTrial.
oncoPlan is a process based tool designed to support the multidisciplinary treatment (medical, radiotherapy and surgery) of cancer patients through the use of flow sheets and evidence based medicine.
oncoMed offers complete support for the medical treatment of cancer patient. The whole process is covered by providing functionality for the doctor, pharmacist and nurse alike.
oncoLink supports cross – hospital exchange of oncology – specific data, thus ensuring that critical elements such as course templates, accumulated dosages and treatment history stay up to date and available for the user.
oncoTrial supports all forms of cancer related clinical studies. A key feature is customizable electronic CRF’s.
OncoPlan
Modern cancer care transcends the boundaries between clinical disciplines thus enabling the best care, but at the same time increasing the amount of information and need of coordination. oncoPlan is a process based tool designed to support this multidisciplinary treatment. Its aim is to provide clinicians an outline of the patient’s planned and actual events in a matter of seconds as well as to facilitate the implementation of the latest evidence based medicine.
Read more
OncoLink
Cancer care is often organized around clusters where patients accordingly receive treatment at several locations over a short period of time. oncoLink supports the need for data exchange of oncology specific data across these locations.
Read more
OncoMed (CYTODOSE)
OncoMed is designed to support all aspects regarding medical treatment of cancer patients. The application thus greatly enhances the quality and efficiency regarding
ordering, production, administration and documentation of cancer related drugs. OncoMed was originally developed by clinicians at The Norwegian Radiumhospital, the largest cancer centre in Northern Europe. It is now in routine use at over 20 hospitals throughout Scandinavia.
Read more